Beyond market averages, investors looking for exceptional returns turn to stock picking. Skillful choices in individual stocks have the power to substantially increase your wealth.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
In the latest session, Essa Pharma Inc (NASDAQ: EPIX) closed at $1.40 down -73.08% from its previous closing price of $5.20. In other words, the price has decreased by -$73.08 from its previous closing price. On the day, 33.54 million shares were traded. EPIX stock price reached its highest trading level at $1.6 during the session, while it also had its lowest trading level at $1.4.
Ratios:
For a deeper understanding of Essa Pharma Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 36.95 and its Current Ratio is at 36.95. In the meantime, Its Debt-to-Equity ratio is 0.00 whereas as Long-Term Debt/Eq ratio is at 0.00.
On March 04, 2021, Piper Sandler started tracking the stock assigning a Overweight rating and target price of $50.
H.C. Wainwright reiterated its Buy rating for the stock on January 11, 2021, while the target price for the stock was revised from $10 to $17.
Insider Transactions:
Additionally, insider trades can be beneficial to investors who want to learn what the management thinks about stock prices in the future. A recent insider transaction in this stock occurred on Oct 07 ’24 when Virsik Peter sold 694 shares for $6.03 per share. The transaction valued at 4,185 led to the insider holds 7,776 shares of the business.
Virsik Peter sold 694 shares of EPIX for $4,164 on Sep 09 ’24. The Chief Operating Officer now owns 8,470 shares after completing the transaction at $6.00 per share. On Sep 03 ’24, another insider, Virsik Peter, who serves as the Chief Operating Officer of the company, sold 2,082 shares for $6.03 each. As a result, the insider received 12,554 and left with 9,164 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, EPIX now has a Market Capitalization of 62116600 and an Enterprise Value of -68235768.
Stock Price History:
The Beta on a monthly basis for EPIX is 1.84, which has changed by -0.731286 over the last 52 weeks, in comparison to a change of 0.31214523 over the same period for the S&P500. Over the past 52 weeks, EPIX has reached a high of $11.67, while it has fallen to a 52-week low of $4.24. The 50-Day Moving Average of the stock is -76.15%, while the 200-Day Moving Average is calculated to be -78.92%.
Shares Statistics:
For the past three months, EPIX has traded an average of 58.40K shares per day and 3456630 over the past ten days. A total of 44.10M shares are outstanding, with a floating share count of 43.38M. Insiders hold about 2.22% of the company’s shares, while institutions hold 79.97% stake in the company. Shares short for EPIX as of 1728950400 were 1148319 with a Short Ratio of 19.66, compared to 1726185600 on 1070717. Therefore, it implies a Short% of Shares Outstanding of 1148319 and a Short% of Float of 4.3.
Earnings Estimates
Currently, 4.0 analysts are dedicated to thoroughly evaluating and rating the performance of Essa Pharma Inc (EPIX) in the stock market.The consensus estimate for the next quarter is -$0.26, with high estimates of -$0.23 and low estimates of -$0.29.
Analysts are recommending an EPS of between -$0.6 and -$0.75 for the fiscal current year, implying an average EPS of -$0.68. EPS for the following year is -$0.83, with 5.0 analysts recommending between -$0.31 and -$1.54.
